SupremeToday Landscape Ad
Back
Next
Judicial Analysis Court Copy Headnote Facts Arguments Court observation
Listen Audio Icon Pause Audio Icon
judgment-img

2023 Supreme(Online)(NCLT) 1075

NATIONAL COMPANY LAW TRIBUNAL
Mr. Shammi Khan, J, Mr. Sameer Kakar, T
Tejas K Shah Resolution Professional of Skylead Chemicals Limited VS
IA/917(AHM)2023 in CP(IB) 113 of 2019



Advocates:
For the Appellants/Petitioners: Mr. Sumit Parikh, Adv., Ms. Aditi Sharma, Adv., Mr. Atul Sharma, Adv.

The court affirmed that the approval of a resolution plan under the IBC is a matter of commercial wisdom of the Committee of Creditors, with limited grounds for judicial review confined to compliance with statutory requirements.

Headnote:(A) Insolvency and Bankruptcy Code, 2016 - Sections 30(6) and 31 - Resolution Plan - Approval of the Resolution Plan submitted by Rolence Pharma & Chemicals LLP under CIRP process for Skylead Chemicals Ltd. - CoC approved the plan with 100% voting shares - The Tribunal emphasized that the decision on resolution plans is within the commercial wisdom of the CoC and limited judicial review applies regarding compliance with statutory requirements. (Paras III, VI, IX, XII)

(B) Judicial Authority - The role of Adjudicating Authority is to ensure the Resolution Plan conforms to the provisions of the IBC and does not enter the commercial wisdom exercised by the CoC. (Paras VI, VIII)

Facts of the case:
The Applicant sought approval for a revised Resolution Plan for Skylead Chemicals Ltd., which was admitted for CIRP. The CoC approved the plan amidst various meetings and discussions, addressing the financial recovery and restructuring of the company. (Paras 1, 2, 16, 37)

Findings of Court:
The Tribunal found the plan to be compliant with requirements under the IBC and emphasized the necessity of adherence to timelines and conditions outlined in the Resolution Plan, ensuring the implementation and monitoring of the process. (Paras IX, XII, XV)

Issues: The primary issues included the viability of the approved Resolution Plan and the compliance with statutory provisions, alongside the responsibilities of the Resolution Applicant in the repayment process. (Paras IV, VI, IX)

Ratio Decidendi: The court asserted that the decision-making concerning the resolution process is anchored in the collective commercial wisdom of the CoC, which cannot be interfered with unless there are glaring legal shortcomings in the approved plan. (Paras VI, VIII, XII)

Result: Approval of the Resolution Plan is granted with the conditions stipulated for compliance. (Paras XI, XII)

ORDER

[Per: Bench]

1. This application is filed by the Resolution Professional of Skylead Chemicals Limited (Corporate Debtor) under Section 30 (6) and Section 31 of the Insolvency and Bankruptcy Code, 2016 (Code) r.w. Regulation 39(4) of Insolvency and Bankruptcy Board of India (Insolvency Process of Corporate Persons) Regulations, 2016 seeking the following prayers:

a. Your lordship may be pleased to allow the present application;

b. Your lordship may be pleased to approve final revised Resolution Plan dated 02.06.2023 along with its addendum dated 28.06.2023 and 14.07.2023 submitted by M/s. Rolence Pharma & Chemicals LLP;

c. To approve the Resolution Plan approved by the Committee of Creditors in compliance with Section 30 (6) and 31(1) of the Code read with Regulation 39 of the IBBI (Insolvency Resolution Process for Corporate Person) Regulations, 2016;

d. Your Lordship may be pleased to grant any other relief or relief as may deem fit in the interest of justice.

2. It is stated that this Tribunal vide its order dated 30.11.2022 admitted the Corporate Debtor – Skylead Chemicals Ltd., to Corporate Insolvency Resolution Process (“CIRP”) in Company Petition No. 113 of 2019 filed by Financial Creditor - Stressed Asset Stabilisation Fund under Section 7 of the Code and thereby appointed the Applicant herein as the Interim Resolution Professional (“IRP”) of the Corporate Debtor.

3. It is stated that the public announcement inviting the claims from all creditors of the Corporate Debtor was made in Form-A on 03.12.2022 wherein the last date for submission of claims was 14.12.2022.

4. It is stated that pursuant to the publication of Form-A dated 03.12.2022, the IRP collated the claims and constituted the Committee of Creditors (“CoC”) on 22.12.2022 and report certifying the constitution of CoC was filed before this Tribunal on 23.12.2022 Subsequently, the IRP filed a report certifying the re- constitution of the CoC, comprising of Stressed Assets Stabilization Fund (“SASF”), having 45.77% voting share and Gujarat State Financial Corporation (“GSFC”), having 54.23% voting share before this Tribunal on 24.03.2023. A copy of the same is annexed as Annexure- C at page no. 21-28 of this application.

5. It is stated that the 1st meeting of CoC was held on 28.12.2022 wherein the Applicant herein was appointed as Resolution Professional (“RP”).

6. It is stated that 2nd meeting of the CoC was held on 21.01.2023 wherein the CoC resolved to publish Expression of Interest (“EoI”) in Form-G. Accordingly, Form-G was published in Times of India (in English) and Divya Bhaskar (in Gujarati) and Financial Express (in English & Gujarati) on 25.01.2023 with the last date of submission of EoI as 09.02.2023. A copy of the publication of Form-G is annexed as Annexure F at page no. 53 of the application.

7. It is stated that 3rd meeting of CoC was held on 08.02.2023 wherein RP appraised the CoC that one email has been received from the Prospective Resolution Application (“PRA”) for the extension of time of EoI. Accordingly, the CoC resolved to extend the last date of EoI from 09.02.2023 to 20.02.2023.

8. It is stated that 4th meeting of the CoC was held on 20.02.2023 wherein the CoC gave approval for E- valuation Matrix & Request for Resolution Plan (“RFRP”) and ratified the CIRP cost incurred by the Applicant.

9. It is stated that 5th meeting of the CoC was held on 12.04.2023 wherein the RP apprised the CoC that till 12.04.2023, three Resolution Plans were received from the following PRAs:-

(i) Shiv Enterprise Jointly with Kudia Brothers,

(ii) Prabodh Steel Pvt. Ltd., and

(iii) Rolence Pharma & Chemicals LLP.

10. It is stated that 6th meeting of the CoC was held on 02.05.2023, wherein the CoC discussed the valuation report of the Corporate Debtor submitted by the registered valuers and further discussed the Resolution Plans submitted by the PRAs.

11. It is stated that in the 7th CoC meeting held on 12.05.2023, the CoC negotiated with the PRAs regarding the Resolution Pla

Click Here to Read the rest of this document
1
2
3
4
5
6
7
8
9
10
11
SupremeToday Portrait Ad
supreme today icon
logo-black

An indispensable Tool for Legal Professionals, Endorsed by Various High Court and Judicial Officers

Please visit our Training & Support
Center or Contact Us for assistance

qr

Scan Me!

India’s Legal research and Law Firm App, Download now!

For Daily Legal Updates, Join us on :

whatsapp-icon Back to top